CN111925310A - 3-amino-4-arylseleno maleimide compound and preparation method thereof - Google Patents
3-amino-4-arylseleno maleimide compound and preparation method thereof Download PDFInfo
- Publication number
- CN111925310A CN111925310A CN201910670849.2A CN201910670849A CN111925310A CN 111925310 A CN111925310 A CN 111925310A CN 201910670849 A CN201910670849 A CN 201910670849A CN 111925310 A CN111925310 A CN 111925310A
- Authority
- CN
- China
- Prior art keywords
- maleimide
- reaction
- formula
- product
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 maleimide compound Chemical class 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims abstract description 71
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 27
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 26
- 239000001301 oxygen Substances 0.000 claims abstract description 26
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000003960 organic solvent Substances 0.000 claims abstract description 12
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052802 copper Inorganic materials 0.000 claims abstract description 10
- 239000010949 copper Substances 0.000 claims abstract description 10
- 125000003118 aryl group Chemical group 0.000 claims abstract description 8
- 229910052723 transition metal Inorganic materials 0.000 claims abstract description 8
- 150000003624 transition metals Chemical class 0.000 claims abstract description 8
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims abstract description 5
- 238000005691 oxidative coupling reaction Methods 0.000 claims abstract description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 92
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 50
- 239000012074 organic phase Substances 0.000 claims description 44
- 239000008346 aqueous phase Substances 0.000 claims description 43
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 34
- 150000001875 compounds Chemical class 0.000 claims description 26
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 25
- 238000004440 column chromatography Methods 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 24
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical group [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 23
- 239000003480 eluent Substances 0.000 claims description 23
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 22
- 239000003208 petroleum Substances 0.000 claims description 22
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 claims description 13
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 12
- 150000003335 secondary amines Chemical class 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 claims description 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical group CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- 239000002585 base Substances 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- BCLXYIADRSPQJP-UHFFFAOYSA-N 1-(thiophen-2-ylmethyl)pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1CC1=CC=CS1 BCLXYIADRSPQJP-UHFFFAOYSA-N 0.000 claims description 3
- MKRBAPNEJMFMHU-UHFFFAOYSA-N 1-benzylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1CC1=CC=CC=C1 MKRBAPNEJMFMHU-UHFFFAOYSA-N 0.000 claims description 3
- UCCUXODGPMAHRL-UHFFFAOYSA-N 1-bromo-4-iodobenzene Chemical compound BrC1=CC=C(I)C=C1 UCCUXODGPMAHRL-UHFFFAOYSA-N 0.000 claims description 3
- GWQSENYKCGJTRI-UHFFFAOYSA-N 1-chloro-4-iodobenzene Chemical compound ClC1=CC=C(I)C=C1 GWQSENYKCGJTRI-UHFFFAOYSA-N 0.000 claims description 3
- BQTPKSBXMONSJI-UHFFFAOYSA-N 1-cyclohexylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1CCCCC1 BQTPKSBXMONSJI-UHFFFAOYSA-N 0.000 claims description 3
- KGNQDBQYEBMPFZ-UHFFFAOYSA-N 1-fluoro-4-iodobenzene Chemical compound FC1=CC=C(I)C=C1 KGNQDBQYEBMPFZ-UHFFFAOYSA-N 0.000 claims description 3
- UDHAWRUAECEBHC-UHFFFAOYSA-N 1-iodo-4-methylbenzene Chemical compound CC1=CC=C(I)C=C1 UDHAWRUAECEBHC-UHFFFAOYSA-N 0.000 claims description 3
- SCCCFNJTCDSLCY-UHFFFAOYSA-N 1-iodo-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(I)C=C1 SCCCFNJTCDSLCY-UHFFFAOYSA-N 0.000 claims description 3
- NHPPIJMARIVBGU-UHFFFAOYSA-N 1-iodonaphthalene Chemical compound C1=CC=C2C(I)=CC=CC2=C1 NHPPIJMARIVBGU-UHFFFAOYSA-N 0.000 claims description 3
- HIDBROSJWZYGSZ-UHFFFAOYSA-N 1-phenylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC=C1 HIDBROSJWZYGSZ-UHFFFAOYSA-N 0.000 claims description 3
- WGKRMQIQXMJVFZ-UHFFFAOYSA-N 3-iodothiophene Chemical compound IC=1C=CSC=1 WGKRMQIQXMJVFZ-UHFFFAOYSA-N 0.000 claims description 3
- XOKDXPVXJWTSRM-UHFFFAOYSA-N 4-iodobenzonitrile Chemical compound IC1=CC=C(C#N)C=C1 XOKDXPVXJWTSRM-UHFFFAOYSA-N 0.000 claims description 3
- RZVWBASHHLFBJF-UHFFFAOYSA-N methyl piperidine-4-carboxylate Chemical compound COC(=O)C1CCNCC1 RZVWBASHHLFBJF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- XBXHCBLBYQEYTI-UHFFFAOYSA-N piperidin-4-ylmethanol Chemical compound OCC1CCNCC1 XBXHCBLBYQEYTI-UHFFFAOYSA-N 0.000 claims description 3
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 3
- NNGAQKAUYDTUQR-UHFFFAOYSA-N cyclohexanimine Chemical compound N=C1CCCCC1 NNGAQKAUYDTUQR-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- HHLZZPISSWCQHH-UHFFFAOYSA-N 1-(fluoromethyl)-2-iodobenzene Chemical compound FCC1=CC=CC=C1I HHLZZPISSWCQHH-UHFFFAOYSA-N 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- WDODWFPDZYSKIA-UHFFFAOYSA-N benzeneselenol Chemical compound [SeH]C1=CC=CC=C1 WDODWFPDZYSKIA-UHFFFAOYSA-N 0.000 claims 1
- 239000012295 chemical reaction liquid Substances 0.000 claims 1
- 150000003949 imides Chemical class 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- SNHMUERNLJLMHN-IDEBNGHGSA-N iodobenzene Chemical group I[13C]1=[13CH][13CH]=[13CH][13CH]=[13CH]1 SNHMUERNLJLMHN-IDEBNGHGSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 238000002390 rotary evaporation Methods 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 9
- 238000011160 research Methods 0.000 abstract description 5
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 198
- 239000000047 product Substances 0.000 description 111
- 238000005481 NMR spectroscopy Methods 0.000 description 43
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 42
- 230000015572 biosynthetic process Effects 0.000 description 28
- 238000003786 synthesis reaction Methods 0.000 description 28
- 239000000243 solution Substances 0.000 description 27
- 239000011541 reaction mixture Substances 0.000 description 22
- 239000012065 filter cake Substances 0.000 description 21
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 21
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 20
- 229910052799 carbon Inorganic materials 0.000 description 20
- 239000007788 liquid Substances 0.000 description 18
- SEEYREPSKCQBBF-UHFFFAOYSA-N n-methylmaleimide Chemical compound CN1C(=O)C=CC1=O SEEYREPSKCQBBF-UHFFFAOYSA-N 0.000 description 15
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 12
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- UMRSVAKGZBVPKD-UHFFFAOYSA-N acetic acid;copper Chemical compound [Cu].CC(O)=O UMRSVAKGZBVPKD-UHFFFAOYSA-N 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- SKGRFPGOGCHDPC-UHFFFAOYSA-N 1-iodo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(I)C=C1 SKGRFPGOGCHDPC-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 206010048723 Multiple-drug resistance Diseases 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 238000010523 cascade reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001879 copper Chemical class 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical group [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 239000001677 (2R,5R)-1,4-dithiane-2,5-diol Substances 0.000 description 1
- YUIOPHXTILULQC-UHFFFAOYSA-N 1,4-Dithiane-2,5-diol Chemical compound OC1CSC(O)CS1 YUIOPHXTILULQC-UHFFFAOYSA-N 0.000 description 1
- KVBAKSQRUXXHCK-UHFFFAOYSA-N 3,4-Dichloro-5-hydroxy-2H-pyrrol-2-one Chemical compound ClC1=C(Cl)C(=O)NC1=O KVBAKSQRUXXHCK-UHFFFAOYSA-N 0.000 description 1
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 1
- 238000010499 C–H functionalization reaction Methods 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000015537 Protein Kinase C-alpha Human genes 0.000 description 1
- 108010050276 Protein Kinase C-alpha Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000010719 annulation reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229940076286 cupric acetate Drugs 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 125000000593 indol-1-yl group Chemical group [H]C1=C([H])C([H])=C2N([*])C([H])=C([H])C2=C1[H] 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 238000006891 umpolung reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
- C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
- C07D207/456—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Abstract
Description
技术领域technical field
本发明属于有机化合物合成技术领域,尤其是涉及一种3-胺基-4-芳硒基马来酰亚胺化合物及制备方法。The invention belongs to the technical field of organic compound synthesis, in particular to a 3-amino-4-arylselenyl maleimide compound and a preparation method.
背景技术Background technique
马来酰亚胺作为一类重要的酰胺类化合物,广泛存在于天然产物、生物活性分子以及临床药物分子中,并且母体结构还可以通过各种转换反应制备琥珀酰亚胺、吡咯烷、内酰亚胺等衍生物,因此,基于马来酰亚胺化合物不同领域的应用,如何高效绿色地合成具有马来酰亚胺骨架的衍生物一直是有机化学家追求的目标。例如:中山大学的蒋先兴教授利用有机碱催化剂,以1,4-二硫-2,5-二醇和马来酰亚胺为底物,通过非对映选择串联Michael-Aldol[3+2]环化反应制备具有四氢噻吩骨架结构的手性并杂环类化合物(Diastereoselective Synthesis of Biheterocyclic TetrahydrothiopheneDerivatives via Base-Catalyzed Cascade Michael-Aldol[3+2]Annulation of 1,4-Dithiane-2,5-diol with Maleimides,J.Org.Chem.,2015,80, 6870-6874),通过药理活性研究发现此类化合物同时具有很好的生物和药物活性;2008年,A.Yu.Simonov 等人报道了(Synthesis of 4_substituted 3-[3-(dialkylaminomethyl)indol-1-yl]maleimidesand study of their ability to inhibit protein kinase Cα,prevent developmentof multiple drug resistance of tumor cells and cytotoxicity,Russ.Chem.Bull.2008,57,2011-2020;),利用3-氨基-4-芳巯基马来酰亚胺可以抑制蛋白激酶,防止多重的发展肿瘤细胞耐药及细胞毒性。As an important class of amide compounds, maleimide widely exists in natural products, bioactive molecules and clinical drug molecules, and the parent structure can also be prepared by various conversion reactions to succinimide, pyrrolidine, lactam Therefore, based on the application of maleimide compounds in different fields, how to efficiently and greenly synthesize derivatives with maleimide skeleton has always been the goal pursued by organic chemists. For example: Professor Jiang Xianxing of Sun Yat-Sen University used organic base catalysts, 1,4-dithio-2,5-diol and maleimide as substrates to connect Michael-Aldol[3+2] rings through diastereoselective Diastereoselective Synthesis of Biheterocyclic TetrahydrothiopheneDerivatives via Base-Catalyzed Cascade Michael-Aldol[3+2]Annulation of 1,4-Dithiane-2,5-diol with Maleimides, J.Org.Chem., 2015, 80, 6870-6874), through pharmacological activity studies, it was found that such compounds have good biological and pharmaceutical activities at the same time; In 2008, A.Yu.Simonov et al. reported (Synthesis of 4-substituted 3-[3-(dialkylaminomethyl)indol-1-yl]maleimides and study of their ability to inhibit protein kinase Cα, prevent development of multiple drug resistance of tumor cells and cytotoxicity, Russ.Chem.Bull.2008,57,2011- 2020;), the use of 3-amino-4-arylmercaptomaleimide can inhibit protein kinases and prevent the development of multiple drug resistance and cytotoxicity of tumor cells.
正是由于含有马来酰亚胺结构的化合物如此重要,人们对其合成开展了大量研究,尤其是对3-氨基-4- 芳巯基马来酰亚胺化合物的合成,目前已经探索了多条合成路线和方法:It is precisely because the compounds containing maleimide structures are so important that a lot of research has been carried out on their synthesis, especially the synthesis of 3-amino-4-arylmercaptomaleimide compounds. Synthetic route and method:
2002年,Dubinina,G.G.等人报道了(Reactions of 3,4-dichloromaleimideswith N-and S-nucleophiles, Ukrainskii Khimicheskii Zhurnal,68,47-51;2002),利用3,4-二氯马来酰亚胺、芳胺和硫酚在三乙胺条件下回流得到3-氨基-4-芳巯基马来酰亚胺化合物,然而该反应需要价格昂贵的3,4-二氯马来酰亚胺作为原料,甚至使用恶臭的硫酚容易造成环境污染,反应式如下:In 2002, Dubinina, G.G. et al. reported (Reactions of 3,4-dichloromaleimides with N-and S-nucleophiles, Ukrainskii Khimicheskii Zhurnal, 68, 47-51; 2002), using 3,4-dichloromaleimides with N-and S-nucleophiles , arylamine and thiophenol reflux under triethylamine condition to obtain 3-amino-4-arylmercaptomaleimide compound, but this reaction needs expensive 3,4-dichloromaleimide as raw material, Even the use of foul-smelling thiophenols is likely to cause environmental pollution. The reaction formula is as follows:
2018年,东华大学的赵圣印教授等人报道了(Three-Component CouplingReactions of Maleimides,Thiols,and Amines:One-Step Construction of 3,4-Heteroatom-functionalized Maleimides by Copper-Catalyzed C(sp2)-HThioamination,Advanced Synthesis&Catalysis,2018,360,173-179;),利用过渡金属铜/氧气催化马来酰亚胺、芳胺和硫酚的三组分串联反应实现3-氨基-4-芳巯基马来酰亚胺目标化合物的制备,使用恶臭的硫酚容易造成环境污染,反应式如下:In 2018, Professor Zhao Shengyin of Donghua University and others reported (Three-Component CouplingReactions of Maleimides, Thiols, and Amines: One-Step Construction of 3,4-Heteroatom-functionalized Maleimides by Copper-Catalyzed C(sp2)-HThioamination, Advanced Synthesis & Catalysis, 2018, 360, 173-179;), 3-amino-4-arylmercaptomaleimide via the three-component tandem reaction of maleimide, arylamine and thiophenol catalyzed by transition metal copper/oxygen The preparation of the amine target compound, the use of malodorous thiophenols is easy to cause environmental pollution, and the reaction formula is as follows:
近年来,对于硒代的马来酰亚胺也有相关报道,2017年,印度理工学院的Mahiuddin Baidya等人报道了 (Ru(II)-Catalyzed C-H Functionalization onMaleimides with Electrophiles:A Demonstration of Umpolung Strategy,Org.Lett.,2017,19,1902-1905;),利用价格昂贵的钌催化马来酰亚胺与二芳基二硒醚合成3-芳硒基马来酰亚胺,反应式如下:In recent years, seleno-substituted maleimides have also been reported. In 2017, Mahiuddin Baidya et al. from the Indian Institute of Technology reported (Ru(II)-Catalyzed C-H Functionalization on Maleimides with Electrophiles: A Demonstration of Umpolung Strategy, Org. Lett., 2017,19,1902-1905;), utilize expensive ruthenium catalyzed maleimide and diaryl diselenide to synthesize 3-arylselenyl maleimide, the reaction formula is as follows:
虽然现有技术可以解决马来酰亚胺的芳硒基化反应,然而反应过程中使用预先制备的二芳基二硒醚以及价格昂贵的钌催化剂限制了该反应的进一步工业化应用以及分子化合物的药理活性或生物活性研究,并且马来酰亚胺结构中碳碳双键通过双官能团化反应合成一系列的3-胺基-4-芳硒基马来酰亚胺化合物至今未见报道。因此,对于简便、易于处理、底物廉价易得的原料来制备3-胺基-4-芳硒基马来酰亚胺化合物显得尤为重要,尤其是利用单质硒作为硒基化试剂参与的四组分串联反应合成3-胺基-4-芳硒基马来酰亚胺化合物,仍存在继续进行研究和探索的必要,这也是本发明得以完成的基础和动力所在。Although the existing technology can solve the arylselenylation reaction of maleimide, the use of pre-prepared diaryl diselenyl ethers and expensive ruthenium catalysts in the reaction process limits the further industrial application of this reaction and the utilization of molecular compounds. Pharmacological activity or biological activity research, and the synthesis of a series of 3-amino-4-arylselenomaleimide compounds through bifunctionalization of carbon-carbon double bonds in the maleimide structure has not been reported so far. Therefore, it is particularly important to prepare 3-amino-4-arylselenylmaleimide compounds from raw materials that are simple, easy to handle, and cheap and easy to obtain substrates, especially the use of elemental selenium as a selenoylation reagent The 3-amino-4-arylselenyl maleimide compound is synthesized by the series reaction of the components, and there is still a need for continued research and exploration, which is also the basis and motivation for the completion of the present invention.
发明内容SUMMARY OF THE INVENTION
本发明所要解决的技术问题是3-胺基-4-芳硒基马来酰亚胺化合物的制备方法的合成路线问题。The technical problem to be solved by the present invention is the synthetic route problem of the preparation method of the 3-amino-4-arylselenylmaleimide compound.
为解决以上技术问题,本发明提供下述技术方案:For solving the above technical problems, the present invention provides the following technical solutions:
一种3-胺基-4-芳硒基马来酰亚胺化合物的制备方法,在有机溶剂中,氧气条件下,以具有如式(I)所示结构的芳香碘化物、式(II)所示结构的硒粉、(III)所示结构的马来酰亚胺化合物和式(IV)结构所示的二级胺为反应原料,在过渡金属铜催化作用下,通过马来酰亚胺结构中的碳碳双键的氧化偶联反应得到式 (V)所示结构的3-胺基-4-芳硒基马来酰亚胺化合物。A kind of preparation method of 3-amino-4-arylselenyl maleimide compound, in organic solvent, under oxygen condition, with the aromatic iodide having the structure shown in formula (I), formula (II) The selenium powder of the shown structure, the maleimide compound of the structure shown in (III) and the secondary amine shown in the structure of formula (IV) are the reaction raw materials, and under the catalysis of transition metal copper, the maleimide compound is passed through the maleimide. The oxidative coupling reaction of the carbon-carbon double bond in the structure obtains the 3-amino-4-arylselenylmaleimide compound of the structure represented by formula (V).
上述的反应过程,可用下述的反应式表示:The above-mentioned reaction process can be represented by the following reaction formula:
所述(I)所示结构的芳香碘化物、式(II)所示结构的硒粉、式(III)所示结构的马来酰亚胺和式(IV) 结构所示的二级胺的摩尔比为6∶6∶2∶3。The aromatic iodide of the structure shown in (I), the selenium powder of the structure of the formula (II), the maleimide of the structure of the formula (III) and the secondary amine of the structure of the formula (IV) The molar ratio was 6:6:2:3.
(1)芳香碘化物(1) Aromatic iodide
本发明中的芳香碘化物包括碘苯、1-碘萘、4-甲基碘苯、4-氟碘苯、4-氯碘苯、4-溴碘苯、4-硝基碘苯、 4-三氟甲基碘苯、4-氰基碘苯和3-碘噻吩。Aromatic iodides in the present invention include iodobenzene, 1-iodonaphthalene, 4-methyliodobenzene, 4-fluoroiodobenzene, 4-chloroiodobenzene, 4-bromoiodobenzene, 4-nitroiodobenzene, 4- Trifluoromethyliodobenzene, 4-cyanoiodobenzene and 3-iodothiophene.
(2)马来酰亚胺化合物(2) Maleimide compound
本发明中的马来酰亚胺化合物包括马来酰亚胺、N-苯基马来酰亚胺、N-苄基马来酰亚胺、N-环己基马来酰亚胺和N-(2-噻吩甲基)马来酰亚胺Maleimide compounds in the present invention include maleimide, N-phenylmaleimide, N-benzylmaleimide, N-cyclohexylmaleimide and N-( 2-Thienylmethyl)maleimide
(3)二级胺(3) Secondary amine
本发明中的二级胺包括吗啡啉、硫代吗啉、四氢吡咯、环己亚胺、4-哌啶甲醇和4-哌啶甲酸甲酯。Secondary amines in the present invention include morpholine, thiomorpholine, tetrahydropyrrole, cyclohexylimine, 4-piperidinemethanol and methyl 4-piperidinecarboxylate.
(4)过渡金属催化剂铜(4) transition metal catalyst copper
本发明中的过渡金属催化剂铜是醋酸铜、氯化铜、溴化铜或碘化亚铜,优选为醋酸铜,以摩尔量计,所述醋酸铜的用量与所述式(II)用量比为0.1∶1-0.3∶1,优选为0.1。The transition metal catalyst copper in the present invention is copper acetate, copper chloride, copper bromide or cuprous iodide, preferably copper acetate, and in molar terms, the ratio of the consumption of the copper acetate to the consumption of the formula (II) It is 0.1:1-0.3:1, preferably 0.1.
(5)有机溶剂(5) Organic solvent
本发明中的反应溶剂为有机溶剂,所述有机溶剂为二甲基亚砜、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮、二氯甲烷、乙酸乙酯、吡啶、1,4-二氧六烷、1,2-二氯乙烷、乙腈、甲苯、四氢呋喃、乙醇、四氯化碳、氯仿、正丁醇中的至少一种,优选N-甲基吡咯烷酮。The reaction solvent in the present invention is an organic solvent, and the organic solvent is dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, dichloromethane , at least one of ethyl acetate, pyridine, 1,4-dioxane, 1,2-dichloroethane, acetonitrile, toluene, tetrahydrofuran, ethanol, carbon tetrachloride, chloroform, n-butanol, preferably N-methylpyrrolidone.
(6)碱(6) Alkali
本发明中的碱为无机碱,所述碱为碳酸锂、碳酸铯、碳酸钾、碳酸钠、醋酸钠、醋酸锂、磷酸钾、叔丁醇钠、叔丁醇锂或叔丁醇钾,优选为碳酸钠。The base in the present invention is an inorganic base, and the base is lithium carbonate, cesium carbonate, potassium carbonate, sodium carbonate, sodium acetate, lithium acetate, potassium phosphate, sodium tert-butoxide, lithium tert-butoxide or potassium tert-butoxide, preferably for sodium carbonate.
(7)反应温度(7) Reaction temperature
本发明的制备方法中,反应温度为100-120℃,非限定性地例如可为100℃、110℃和120℃,反应温度优选120℃。In the preparation method of the present invention, the reaction temperature is 100-120°C, for example, 100°C, 110°C and 120°C without limitation, and the reaction temperature is preferably 120°C.
(8)反应时间(8) Response time
在本发明的制备方法中,反应时间并无特别的限定,例如可通过液相色谱仪检测目标产物或原料的残留百分比而确定合适的反应时间,其通常为14-18小时,非限定性例如为14小时、15小时、16小时、17 小时或18小时,反应时间优选18小时。In the preparation method of the present invention, the reaction time is not particularly limited. For example, a suitable reaction time can be determined by detecting the residual percentage of the target product or raw material by liquid chromatography, which is usually 14-18 hours. The reaction time is preferably 18 hours, 14 hours, 15 hours, 16 hours, 17 hours or 18 hours.
(9)分离纯化(9) Separation and purification
对反应后所得的混合物可以进行进一步的分离纯化,已得到较纯的最终产品。本领域普通技术人员熟知分离纯化的方法,例如可以采用萃取、柱层析、蒸馏、过滤、离心、洗涤、分馏和吸附或者至少两种的组合等方法进行分离纯化,例如萃取、柱层析。The mixture obtained after the reaction can be further separated and purified to obtain a relatively pure final product. Those of ordinary skill in the art are familiar with separation and purification methods, for example, extraction, column chromatography, distillation, filtration, centrifugation, washing, fractionation and adsorption, or a combination of at least two, can be used for separation and purification, such as extraction and column chromatography.
当然如果需要也可以将获得的反应混合物直接引入到其他工序直接反应来生产其他产品。可选的,在引入到其他工序之前,可以对反应混合物进行预处理,例如,浓缩、萃取和减压蒸馏中的一种或多种实验操作,以得到粗产品或纯的产品,然后引入到其他工序。Of course, if necessary, the obtained reaction mixture can also be directly introduced into other processes for direct reaction to produce other products. Optionally, the reaction mixture can be pre-treated, for example, by one or more experimental operations of concentration, extraction and distillation under reduced pressure, to obtain a crude or pure product, which is then introduced into the other processes.
在一种优选的实施方式中,反应结束后的后处理步骤可为如下方法:反应结束后,将反应液冷却后加入乙酸乙酯稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL乙酸乙酯洗涤滤饼共 3次,然后旋掉溶剂,将浓缩物通过柱色谱分离(其中硅胶为300-400目硅胶),以石油醚和乙酸乙酯混合液为洗脱剂,收集洗脱液,浓缩后得到目标产物。In a preferred embodiment, the post-processing step after the reaction is completed can be the following method: after the reaction is completed, the reaction solution is cooled and then diluted with ethyl acetate, the diluted solution is transferred to a separatory funnel, saturated with Extract with brine, separate the aqueous phase and the organic phase, and then extract the aqueous phase with ethyl acetate three times, combine the organic phases, add 5 g of anhydrous sodium sulfate, stand for 30 min, and wash the filter cake with 5 mL of ethyl acetate each time for a total of 3 times. Then spin off the solvent, separate the concentrate by column chromatography (silica gel is 300-400 mesh silica gel), use petroleum ether and ethyl acetate mixture as eluent, collect the eluate, and concentrate to obtain the target product.
本发明提供的3-氨基-4-芳硒基马来酰亚胺的制备方法具有如下有益效果:The preparation method of 3-amino-4-arylselenyl maleimide provided by the invention has the following beneficial effects:
a)反应高效率、高收率、后处理简便;a) high reaction efficiency, high yield and easy post-processing;
b)利用单质硒作为硒基化试剂参与四组分的串联反应;b) using elemental selenium as a selenoylation reagent to participate in the tandem reaction of four components;
c)利用廉价易的铜/氧气作为催化体系;c) Utilize cheap and easy copper/oxygen as catalytic system;
本发明以以具有如式(I)所示结构的芳香碘化物、式(II)所示结构的硒粉、式(III)所示结构的马来酰亚胺和式(IV)结构所示的二级胺为反应原料,在过渡金属铜/氧气催化作用下,通过马来酰亚胺结构中的碳碳双键的氧化偶联反应得到式(V)所示结构的3-胺基-4-芳硒基马来酰亚胺化合物。该合成方法将是作为操作简便、成本低廉的3-氨基-4-芳硒基马来酰亚胺合成方法的重要发展和补充,为马来酰亚胺衍生物的分子设计与合成提供新策略,具有重要的社会意义和经济意义。The present invention is represented by an aromatic iodide having a structure represented by formula (I), a selenium powder having a structure represented by formula (II), a maleimide having a structure represented by formula (III) and a structure represented by formula (IV) The secondary amine is the reaction raw material, under the catalysis of transition metal copper/oxygen, through the oxidative coupling reaction of the carbon-carbon double bond in the maleimide structure to obtain the 3-amino- 4-Arylselenomaleimide compound. This synthetic method will be an important development and supplement for the facile and low-cost synthetic method of 3-amino-4-arylselenylmaleimide, and provide a new strategy for the molecular design and synthesis of maleimide derivatives , has important social and economic significance.
具体实施方式Detailed ways
下面通过具体的实施例对本发明进行详细说明,但这些例举性实施方式的用途和目的仅用来例举本发明,并非对本发明的实际保护范围构成任何形式的任何限定,更非将本发明的保护范围局限于此。The present invention will be described in detail below through specific examples, but the purposes and purposes of these exemplary embodiments are only used to illustrate the present invention, and do not constitute any limitation to the actual protection scope of the present invention, nor do they limit the present invention. The scope of protection is limited to this.
以下实施例所给出的新化合物的数据和纯度均通过核磁共振鉴定。The data and purity of the novel compounds given in the following examples were identified by nuclear magnetic resonance.
实施例1Example 1
1-甲基-3-吗啡啉基-4-(1-萘硒基)马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-(1-naphthylselenyl)maleimide
在室温下,将1-碘萘(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol, 1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率88%,产物重量为70mg。At room temperature, 1-iodonaphthalene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5equiv) , copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred for 18 h at the reaction temperature of 120 °C . The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 88%, and the weight of the product was 70 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ8.10(d,J=8.2Hz,1H),7.82(d,J=7.9Hz,1H),7.70(d,J=7.7Hz,1H), 7.56-7.49(m,2H),7.37-7.32(m,2H),4.13(t,J=4.70Hz,4H),3.58(t,J=4.70Hz,4H),3.06(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 8.10 (d, J=8.2 Hz, 1H), 7.82 (d, J=7.9 Hz, 1H), 7.70 (d, J=7.7 Hz, 1H), 7.56- 7.49(m, 2H), 7.37-7.32(m, 2H), 4.13(t, J=4.70Hz, 4H), 3.58(t, J=4.70Hz, 4H), 3.06(s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.3,166.6,150.5,134.1,132.3,131.3,128.7,127.4,127.3,126.6,126.4, 126.1,125.5,85.8,67.0,48.5,24.5; 13 C NMR (125MHz, CDCl 3 ): δ 170.3, 166.6, 150.5, 134.1, 132.3, 131.3, 128.7, 127.4, 127.3, 126.6, 126.4, 126.1, 125.5, 85.8, 67.0, 48.5, 24.5;
HRMS(ESI):calcd for C19H18N2O3Se[M+H]+403.0562,found 403.0566。HRMS (ESI): calcd for C19H18N2O3Se [ M +H] + 403.0562 , found 403.0566.
实施例2Example 2
1-甲基-3-吗啡啉基-4-(4-甲基苯硒基)马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-(4-methylphenylselenoyl)maleimide
在室温下,将4-甲基碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol, 1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率95%,产物重量为69mg。At room temperature, 4-methyliodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5 equiv), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, at a reaction temperature of 120 °C Stir for 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 95%, and the weight of the product was 69 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.22(d,J=8.0Hz,2H),7.06(d,J=8.0Hz,2H),4.15(t,J=4.70Hz,4H),3.67 (t,J=4.70Hz,4H),3.03(s,3H),2.29(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.22 (d, J=8.0 Hz, 2H), 7.06 (d, J=8.0 Hz, 2H), 4.15 (t, J=4.70 Hz, 4H), 3.67 ( t, J=4.70Hz, 4H), 3.03 (s, 3H), 2.29 (s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.5,166.8,149.6,136.7,135.9,130.3,130.2,129.9,128.5,87.8,66.9, 48.5,24.4,20.9; 13 C NMR (125MHz, CDCl 3 ): δ 170.5, 166.8, 149.6, 136.7, 135.9, 130.3, 130.2, 129.9, 128.5, 87.8, 66.9, 48.5, 24.4, 20.9;
HRMS(ESI):calcd for C16H18N2O3Se[M+H]+367.0562,found 367.0568。HRMS (ESI): calcd for C16H18N2O3Se [ M +H] + 367.0562 , found 367.0568.
实施例3Example 3
1-甲基-3-吗啡啉基-4-(4-氟苯硒基)马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-(4-fluorophenylselenoyl)maleimide
在室温下,将4-氟碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol, 1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率71%,产物重量为52mg。At room temperature, 4-fluoroiodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5equiv) were mixed together ), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 120 °C 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 71%, and the weight of the product was 52 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.34-7.31(m,2H),6.97(t,J=8.7Hz,2H),4.17(t,J=4.70Hz,4H),3.70(t, J=4.70Hz,4H),3.03(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.34-7.31 (m, 2H), 6.97 (t, J=8.7 Hz, 2H), 4.17 (t, J=4.70 Hz, 4H), 3.70 (t, J =4.70Hz, 4H), 3.03 (s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.3,166.6,162.1(d,JF=246.5Hz),149.7,131.8(d,JF=7.7Hz),126.6(d, JF=3.4Hz),116.6(d,JF=21.8Hz),87.4,66.9,48.6,4.4; 13 C NMR (125 MHz, CDCl 3 ): δ 170.3, 166.6, 162.1 (d, J F =246.5 Hz), 149.7, 131.8 (d, J F =7.7 Hz), 126.6 (d, J F =3.4 Hz) , 116.6 (d, J F =21.8Hz), 87.4, 66.9, 48.6, 4.4;
所得产物的核磁共振氟谱的数据如下:The data of the fluorine nuclear magnetic resonance spectrum of the obtained product are as follows:
19F NMR(470MHz,CDCl3):δ-115.1(s,1F); 19 F NMR (470 MHz, CDCl 3 ): δ-115.1 (s, 1F);
HRMS(ESI):calcd for C15H15FN2O3Se[M+H]+371.0311,found 371.0317。HRMS (ESI): calcd for C15H15FN2O3Se [ M +H] + 371.0311 , found 371.0317.
实施例4Example 4
1-甲基-3-吗啡啉基-4-(4-氯苯硒基)马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-(4-chlorophenylselenoyl)maleimide
在室温下,将4-氯碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol, 1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率74%,产物重量为57mg。At room temperature, 4-chloroiodobenzene (0.6 mmol, 3 equiv), selenium powder (0.6 mmol, 3 equiv), N-methylmaleimide (0.2 mmol, 1 equiv), morpholine (0.3 mmol, 1.5 equiv) were mixed together ), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 120 °C 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 74%, and the weight of the product was 57 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.23(dd,J=16.5,8.7Hz,4H),4.17(t,J=4.70Hz,4H),3.70(t,J=4.70Hz, 4H),3.04(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.23 (dd, J=16.5, 8.7 Hz, 4H), 4.17 (t, J=4.70 Hz, 4H), 3.70 (t, J=4.70 Hz, 4H), 3.04(s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.2,166.5,150.0,132.8,130.7,130.6,129.6,86.4,66.9,48.6,24.5; 13 C NMR (125 MHz, CDCl 3 ): δ 170.2, 166.5, 150.0, 132.8, 130.7, 130.6, 129.6, 86.4, 66.9, 48.6, 24.5;
HRMS(ESI):calcd for C15H15ClN2O3Se[M+H]+387.0015,found 387.0022。HRMS (ESI): calcd for C15H15ClN2O3Se [ M +H] + 387.0015 , found 387.0022.
实施例5Example 5
1-甲基-3-吗啡啉基-4-(4-溴苯硒基)马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-(4-bromophenylselenoyl)maleimide
在室温下,将4-溴碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol,1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率55%,产物重量为47mg。At room temperature, 4-bromoiodobenzene (0.6 mmol, 3 equiv), selenium powder (0.6 mmol, 3 equiv), N-methylmaleimide (0.2 mmol, 1 equiv), morpholine (0.3 mmol, 1.5 equiv) were combined ), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 120 °C 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 55%, and the weight of the product was 47 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.36(d,J=8.3Hz,2H),7.18(d,J=8.4Hz,2H),4.17(t,J=4.70Hz,4H),3.70 (t,J=4.70Hz,4H),3.04(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.36 (d, J=8.3 Hz, 2H), 7.18 (d, J=8.4 Hz, 2H), 4.17 (t, J=4.70 Hz, 4H), 3.70 ( t, J=4.70Hz, 4H), 3.04(s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.2,166.5,150.1,132.5,131.4,130.9,120.7,86.3,66.9,48.6,24.5; 13 C NMR (125 MHz, CDCl 3 ): δ 170.2, 166.5, 150.1, 132.5, 131.4, 130.9, 120.7, 86.3, 66.9, 48.6, 24.5;
HRMS(ESI):calcd for C15H16BrN2O3Se[M+H]+430.9510,found 430.9509。HRMS (ESI): calcd for C15H16BrN2O3Se [ M +H] + 430.9510 , found 430.9509.
实施例6Example 6
1-甲基-3-吗啡啉基-4-(4-硝基苯硒基)马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-(4-nitrophenylselenoyl)maleimide
在室温下,将4-硝基碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol, 1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率47%,产物重量为37mg。At room temperature, 4-nitroiodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5 equiv), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, at a reaction temperature of 120 °C Stir for 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 47%, and the weight of the product was 37 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ8.09(d,J=8.7Hz,2H),7.40(d,J=8.7Hz,2H),4.19(t,J=4.70Hz,4H),3.73 (t,J=4.70Hz,4H),3.10(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 8.09 (d, J=8.7 Hz, 2H), 7.40 (d, J=8.7 Hz, 2H), 4.19 (t, J=4.70 Hz, 4H), 3.73 ( t, J=4.70Hz, 4H), 3.10(s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ169.8,166.1,150.9,146.4,143.1,128.4,124.3,83.9,66.9,48.7,24.6; 13 C NMR (125 MHz, CDCl 3 ): δ 169.8, 166.1, 150.9, 146.4, 143.1, 128.4, 124.3, 83.9, 66.9, 48.7, 24.6;
HRMS(ESI):calcd for C15H15N3O5Se[M+H]+398.0256,found 398.0259。HRMS (ESI): calcd for C15H15N3O5Se [ M +H] + 398.0256 , found 398.0259 .
实施例7Example 7
1-甲基-3-吗啡啉基-4-(4-三氟甲基苯硒基)马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-(4-trifluoromethylphenylselenoyl)maleimide
在室温下,将4-三氟甲基碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2 mmol,1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv) 和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率38%,产物重量为32mg。At room temperature, 4-trifluoromethyl iodobenzene (0.6 mmol, 3 equiv), selenium powder (0.6 mmol, 3 equiv), N-methylmaleimide (0.2 mmol, 1 equiv), morpholine (0.3 mmol, 1 equiv) were mixed together , 1.5 equiv), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and reacted at 120 °C Stir at temperature for 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: diethyl ether=8 : 1), the product was a yellow liquid, the yield was 38%, and the weight of the product was 32 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.48(d,J=8.1Hz,2H),7.38(d,J=8.1Hz,2H),4.18(t,J=4.70Hz,4H),3.71 (t,J=4.70Hz,4H),3.06(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.48 (d, J=8.1 Hz, 2H), 7.38 (d, J=8.1 Hz, 2H), 4.18 (t, J=4.70 Hz, 4H), 3.71 ( t, J=4.70Hz, 4H), 3.06 (s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.0,166.3,150.6,137.9,128.7(q,JF=32.9Hz),128.7,126.1(q,JF=3.9 Hz),124.0(q,JF=270.4Hz),85.0,66.9,48.6,24.5; 13 C NMR (125 MHz, CDCl 3 ): δ 170.0, 166.3, 150.6, 137.9, 128.7 (q, J F =32.9 Hz), 128.7, 126.1 (q, J F =3.9 Hz), 124.0 (q, J F = 32.9 Hz) = 270.4Hz), 85.0, 66.9, 48.6, 24.5;
所得产物的核磁共振氟谱的数据如下:The data of the fluorine nuclear magnetic resonance spectrum of the obtained product are as follows:
19F NMR(470MHz,CDCl3):δ-62.6(s,3F); 19 F NMR (470 MHz, CDCl 3 ): δ-62.6 (s, 3F);
HRMS(ESI):calcd for C16H15F3N2O3Se[M+H]+421.0279,found 421.0280。HRMS (ESI): calcd for C16H15F3N2O3Se [ M +H] + 421.0279 , found 421.0280.
实施例8Example 8
1-甲基-3-吗啡啉基-4-(4-氰基苯硒基)马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-(4-cyanophenylselenyl)maleimide
在室温下,将4-氰基碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol, 1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率51%,产物重量为38mg。At room temperature, 4-cyanoiodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5 equiv), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, at a reaction temperature of 120 °C Stir for 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 51%, and the weight of the product was 38 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.52(d,J=8.3Hz,2H),7.37(d,J=8.3Hz,2H),4.19(t,J=4.70Hz,4H),3.74(t,J=4.70Hz,4H),3.08(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.52 (d, J=8.3 Hz, 2H), 7.37 (d, J=8.3 Hz, 2H), 4.19 (t, J=4.70 Hz, 4H), 3.74 ( t, J=4.70Hz, 4H), 3.08 (s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ169.9,166.2,150.9,140.4,132.7,128.7,118.6,109.9,84.2,66.9,48.7,24.6; 13 C NMR (125 MHz, CDCl 3 ): δ 169.9, 166.2, 150.9, 140.4, 132.7, 128.7, 118.6, 109.9, 84.2, 66.9, 48.7, 24.6;
HRMS(ESI):calcd for C16H15N3O3Se[M+H]+378.0358,found 378.0360。HRMS (ESI): calcd for C16H15N3O3Se [ M +H] + 378.0358 , found 378.0360.
实施例9Example 9
1-甲基-3-吗啡啉基-4-(3-噻吩基)马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-(3-thienyl)maleimide
在室温下,将3-碘噻吩(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol, 1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率82%,产物重量为59mg。At room temperature, 3-iodothiophene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5equiv) , copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred for 18 h at the reaction temperature of 120 °C . The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 82%, and the weight of the product was 59 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.32-7.31(m,1H),7.21(d,J=1.9Hz,1H),7.05-7.04(m,1H),4.19(t, J=4.70Hz,4H),3.72(t,J=4.70Hz,4H),3.03(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.32-7.31 (m, 1H), 7.21 (d, J=1.9 Hz, 1H), 7.05-7.04 (m, 1H), 4.19 (t, J=4.70 Hz) , 4H), 3.72 (t, J=4.70Hz, 4H), 3.03 (s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.4,166.7,149.1,130.2,126.7,124.8,124.5,88.1,66.9,48.6,24.4; 13 C NMR (125 MHz, CDCl 3 ): δ 170.4, 166.7, 149.1, 130.2, 126.7, 124.8, 124.5, 88.1, 66.9, 48.6, 24.4;
HRMS(ESI):calcd for C13H14N2O3SSe[M+H]+358.9969,found 358.9970。HRMS (ESI): calcd for C13H14N2O3SSe [ M +H] + 358.9969 , found 358.9970.
实施例10Example 10
3-吗啡啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of 3-Mormorpholinyl-4-Phenylselenomaleimide Compounds
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、马来酰亚胺(0.2mmol,1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色固体,熔点:190-191℃,收率60%,产物重量为40mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), maleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5equiv), copper acetate (0.02mmol) , 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at a reaction temperature of 120 °C for 18 h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: diethyl ether=8 : 1), the product is a yellow solid, the melting point is 190-191° C., the yield is 60%, and the weight of the product is 40 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,DMSO-D6):δ10.9(s,1H),7.32-7.27(m,4H),7.21-7.18(m,1H),4.03(t,J=4.70Hz, 4H),3.57(t,J=4.70Hz,4H); 1 H NMR (500MHz, DMSO-D6): δ 10.9 (s, 1H), 7.32-7.27 (m, 4H), 7.21-7.18 (m, 1H), 4.03 (t, J=4.70Hz, 4H), 3.57(t, J=4.70Hz, 4H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,DMSO-D6):δ170.4,167.5,150.7,132.7,129.4,128.2,126.0,85.5,66.1,48.0; 13 C NMR (125MHz, DMSO-D6): δ 170.4, 167.5, 150.7, 132.7, 129.4, 128.2, 126.0, 85.5, 66.1, 48.0;
HRMS(ESI):calcd for C14H14N2O3Se[M+H]+339.0249,found 339.0251。HRMS (ESI): calcd for C14H14N2O3Se [ M +H] + 339.0249 , found 339.0251.
实施例11Example 11
1-苯基-3-吗啡啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-Phenyl-3-Mormorpholinyl-4-Phenylselenomaleimide Compounds
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-苯基马来酰亚胺(0.2mmol,1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率81%,产物重量为67mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-phenylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5equiv), acetic acid Copper (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at 120 °C for 18 h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: diethyl ether=8 : 1), the product was a yellow liquid, the yield was 81%, and the weight of the product was 67 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.46-7.43(m,2H),7.40-7.32(m,5H),7.29-7.21(m,3H),4.19(t,J=4.70 Hz,4H),3.69(t,J=4.70Hz,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.46-7.43 (m, 2H), 7.40-7.32 (m, 5H), 7.29-7.21 (m, 3H), 4.19 (t, J=4.70 Hz, 4H) , 3.69(t, J=4.70Hz, 4H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ169.1,165.5,149.2,131.9,131.8,129.9,129.5,128.9,127.7,126.9,126.3, 88.5,66.9,48.7; 13 C NMR (125MHz, CDCl 3 ): δ 169.1, 165.5, 149.2, 131.9, 131.8, 129.9, 129.5, 128.9, 127.7, 126.9, 126.3, 88.5, 66.9, 48.7;
HRMS(ESI):calcd for C20H18N2O3Se[M+H]+415.0562,found 415.0567。HRMS (ESI): calcd for C20H18N2O3Se [ M +H] + 415.0562 , found 415.0567.
实施例12Example 12
1-苄基-3-吗啡啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-benzyl-3-morpholinyl-4-phenylselenomaleimide compounds
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-苄基马来酰亚胺(0.2mmol,1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率81%,产物重量为69mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-benzylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5equiv), acetic acid Copper (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at 120 °C for 18 h at the reaction temperature. The reaction mixture was cooled, then ethyl acetate was added for dilution, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted with ethyl acetate three times, and combined. To the organic phase, add 5g of anhydrous sodium sulfate, stand still for 30min, wash the filter cake three times with 5mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether:diethyl ether=8 : 1), the product was a yellow liquid, the yield was 81%, and the weight of the product was 69 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.41-7.39(m,2H),7.36-7.22(m,8H),4.72(s,2H),4.16(t,J=4.70Hz,4H), 3.66(t,J=4.70Hz,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.41-7.39 (m, 2H), 7.36-7.22 (m, 8H), 4.72 (s, 2H), 4.16 (t, J=4.70 Hz, 4H), 3.66 (t, J=4.70Hz, 4H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.0,166.3,149.7,136.5,132.3,129.5,129.4,128.6,128.6,127.7,126.7, 87.2,66.9,48.5,42.1; 13 C NMR (125 MHz, CDCl 3 ): δ 170.0, 166.3, 149.7, 136.5, 132.3, 129.5, 129.4, 128.6, 128.6, 127.7, 126.7, 87.2, 66.9, 48.5, 42.1;
HRMS(ESI):calcd for C21H20N2O3Se[M+H]+429.0718,found 429.0719。HRMS (ESI): calcd for C21H20N2O3Se [ M +H] + 429.0718 , found 429.0719.
实施例13Example 13
1-环己基-3-吗啡啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-cyclohexyl-3-morpholinyl-4-phenylselenomaleimide compounds
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-环己基马来酰亚胺(0.2mmol, 1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率83%,产物重量为70mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-cyclohexylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5equiv), acetic acid Copper (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at 120 °C for 18 h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 83%, and the weight of the product was 70 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.30-7.28(m,2H),7.26-7.23(m,2H),7.19(t,J=7.0Hz,1H),4.11(t,J=4.70 Hz,4H),3.96(tt,J=8.3,3.4Hz,1H),3.66(t,J=4.70Hz,4H),2.10-2.03(m,2H),1.82(d,J=3.1Hz,2H), 1.68-1.66(m,2H),1.34-1.18(m,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.30-7.28 (m, 2H), 7.26-7.23 (m, 2H), 7.19 (t, J=7.0 Hz, 1H), 4.11 (t, J=4.70 Hz) , 4H), 3.96 (tt, J=8.3, 3.4Hz, 1H), 3.66 (t, J=4.70Hz, 4H), 2.10-2.03 (m, 2H), 1.82 (d, J=3.1Hz, 2H) , 1.68-1.66 (m, 2H), 1.34-1.18 (m, 4H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.2,166.4,149.5,132.4,129.4,129.3,126.6,87.6,66.9,51.4,48.4,29.9, 26.0,25.2; 13 C NMR (125 MHz, CDCl 3 ): δ 170.2, 166.4, 149.5, 132.4, 129.4, 129.3, 126.6, 87.6, 66.9, 51.4, 48.4, 29.9, 26.0, 25.2;
HRMS(ESI):calcd for C20H24N2O3Se[M+H]+421.1031,found 421.1033。HRMS (ESI): calcd for C20H24N2O3Se[ M + H] + 421.1031 , found 421.1033 .
实施例14Example 14
1-(2-噻吩甲基)-3-吗啡啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-(2-Thienylmethyl)-3-morpholinyl-4-phenylselenomaleimide Compounds
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-(2-噻吩甲基)马来酰亚胺(0.2 mmol,1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv) 和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色固体,熔点:58-59℃,收率82%,产物重量为71mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-(2-thienylmethyl)maleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5 equiv), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times at a reaction temperature of 120 °C Stir for 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: diethyl ether=8 : 1), the product was a yellow solid, melting point: 58-59° C., yield 82%, and product weight was 71 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.30-7.28(m,2H),7.26-7.19(m,4H),7.08(d,J=3.0Hz,1H),6.94-6.92(m, 1H),4.87(s,2H),4.13(t,J=4.70Hz,4H),3.63(t,J=4.70Hz,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.30-7.28 (m, 2H), 7.26-7.19 (m, 4H), 7.08 (d, J=3.0 Hz, 1H), 6.94-6.92 (m, 1H) , 4.87(s, 2H), 4.13(t, J=4.70Hz, 4H), 3.63(t, J=4.70Hz, 4H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ169.5,165.9,149.6,138.3,132.2,129.5,129.4,127.6,126.8,126.7,125.7, 87.3,66.9,48.5,36.2; 13 C NMR (125 MHz, CDCl 3 ): δ 169.5, 165.9, 149.6, 138.3, 132.2, 129.5, 129.4, 127.6, 126.8, 126.7, 125.7, 87.3, 66.9, 48.5, 36.2;
HRMS(ESI):calcd for C19H18N2O3SSe[M+H]+435.0282,found 435.0288。HRMS (ESI): calcd for C19H18N2O3SSe [ M +H] + 435.0282 , found 435.0288.
实施例15Example 15
1-甲基-3-吗啡啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-morpholinyl-4-phenylselenomaleimide
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol,1equiv)、吗啡啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率85%,产物重量为60mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), morpholine (0.3mmol, 1.5equiv), acetic acid Copper (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, and stirred at 120 °C for 18 h at the reaction temperature. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: diethyl ether=8 : 1), the product was a yellow liquid, the yield was 85%, and the weight of the product was 60 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.31-7.30(m,2H),7.26-7.23(m,2H),7.20(t,J=7.0Hz,1H),4.16(t,J=4.70 Hz,4H),3.66(t,J=4.70Hz,4H),3.0(s,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.31-7.30 (m, 2H), 7.26-7.23 (m, 2H), 7.20 (t, J=7.0 Hz, 1H), 4.16 (t, J=4.70 Hz) , 4H), 3.66 (t, J=4.70Hz, 4H), 3.0 (s, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.4,166.7,149.8,132.3,129.4,129.3,126.7,87.0,66.9,48.5,24.4 13 C NMR (125 MHz, CDCl 3 ): δ 170.4, 166.7, 149.8, 132.3, 129.4, 129.3, 126.7, 87.0, 66.9, 48.5, 24.4
HRMS(ESI):calcd for C15H16N2O3Se[M+H]+353.0405,found 353.0401。HRMS (ESI): calcd for C15H16N2O3Se [ M +H] + 353.0405 , found 353.0401.
实施例16Example 16
1-甲基-3-硫代吗啉基-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-thiomorpholinyl-4-phenylselenomaleimide Compounds
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol,1equiv)、硫代吗啉(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,- 甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率77%,产物重量为56mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), thiomorpholine (0.3mmol, 1.5equiv) , copper acetate (0.02mmol, 0.1equiv), sodium carbonate (0.8mmol, 4equiv) and 1mL N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, stirred at 120 ° C reaction temperature for 18h . The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 77%, and the weight of the product was 56 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.31-7.30(m,2H),7.26-7.23(m,2H),7.21-7.18(m,1H),4.35(t,J=4.70Hz, 4H),3.04(s,3H),2.69(t,J=4.70Hz,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.31-7.30 (m, 2H), 7.26-7.23 (m, 2H), 7.21-7.18 (m, 1H), 4.35 (t, J=4.70 Hz, 4H) , 3.04(s, 3H), 2.69(t, J=4.70Hz, 4H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.3,166.7,150.2,132.4,129.4,129.4,126.7,87.6,51.2,28.1,24.5; 13 C NMR (125 MHz, CDCl 3 ): δ 170.3, 166.7, 150.2, 132.4, 129.4, 129.4, 126.7, 87.6, 51.2, 28.1, 24.5;
HRMS(ESI):calcd for C15H16N2O2SSe[M+H]+369.0177,found 369.0179。HRMS (ESI): calcd for C15H16N2O2SSe [M + H] + 369.0177 , found 369.0179.
实施例17Example 17
1-甲基-3-四氢吡咯基-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-tetrahydropyrrolyl-4-phenylselenomaleimide Compounds
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol,1equiv)、四氢吡咯(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,- 甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率74%,产物重量为50mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), tetrahydropyrrole (0.3mmol, 1.5equiv), Copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen and replaced three times, and stirred at 120°C for 18 h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 74%, and the weight of the product was 50 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.31(d,J=7.4Hz,2H),7.22(t,J=7.3Hz,2H),7.15(t,J=7.2Hz,1H),4.03 (t,J=6.8Hz,4H),3.06(s,3H),1.90(t,J=6.8Hz,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.31 (d, J=7.4 Hz, 2H), 7.22 (t, J=7.3 Hz, 2H), 7.15 (t, J=7.2 Hz, 1H), 4.03 ( t, J=6.8Hz, 4H), 3.06 (s, 3H), 1.90 (t, J=6.8Hz, 4H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ171.4,166.2,149.9,135.0,129.2,128.8,126.1,82.2,51.4,25.1,24.3; 13 C NMR (125 MHz, CDCl 3 ): δ 171.4, 166.2, 149.9, 135.0, 129.2, 128.8, 126.1, 82.2, 51.4, 25.1, 24.3;
HRMS(ESI):calcd for C15H16N2O2Se[M+H]+337.0456,found 337.0458。HRMS (ESI): calcd for C15H16N2O2Se [M + H] + 337.0456 , found 337.0458.
实施例18Example 18
1-甲基-3-环庚胺基-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-Methyl-3-cycloheptamino-4-phenylselenomaleimide
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol,1equiv)、环己亚胺(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,- 甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率80%,产物重量为58mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), cyclohexylimide (0.3mmol, 1.5equiv) , copper acetate (0.02mmol, 0.1equiv), sodium carbonate (0.8mmol, 4equiv) and 1mL N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, stirred at 120 ° C reaction temperature for 18h . The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 80%, and the weight of the product was 58 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.30(d,J=7.7Hz,2H),7.21(t,J=7.3Hz,2H),7.15(t,J=7.2Hz,1H),4.07 (t,J=6.1Hz,4H),3.04(s,3H),1.80-1.79(m,4H),1.57-1.56(m,4H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.30 (d, J=7.7 Hz, 2H), 7.21 (t, J=7.3 Hz, 2H), 7.15 (t, J=7.2 Hz, 1H), 4.07 ( t, J=6.1Hz, 4H), 3.04 (s, 3H), 1.80-1.79 (m, 4H), 1.57-1.56 (m, 4H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.9,166.2,150.5,134.2,129.2,128.8,126.1,82.7,52.9,28.4,26.3,24.4; 13 C NMR (125 MHz, CDCl 3 ): δ 170.9, 166.2, 150.5, 134.2, 129.2, 128.8, 126.1, 82.7, 52.9, 28.4, 26.3, 24.4;
HRMS(ESI):calcd for C17H20N2O2Se[M+H]+365.0769,found 365.0770。HRMS (ESI): calcd for C17H20N2O2Se [ M + H] + 365.0769, found 365.0770.
实施例19Example 19
1-甲基-3-(4-哌啶甲醇基)-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-methyl-3-(4-piperidinemethanol)-4-phenylselenomaleimide
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol,1equiv)、 4-哌啶甲醇(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,- 甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率58%,产物重量为44mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), 4-piperidinemethanol (0.3mmol, 1.5equiv) were mixed together ), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, stirring at a reaction temperature of 120 ° C 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 58%, and the weight of the product was 44 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.32-7.30(m,2H),7.24-7.21(m,2H),7.18-7.16(m,1H),5.18(d,J=13.3Hz, 2H),3.46(d,J=5.9Hz,2H),3.04(s,3H),1.82-1.79(m,3H),1.64(s,2H),1.29-1.23(m,3H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.32-7.30 (m, 2H), 7.24-7.21 (m, 2H), 7.18-7.16 (m, 1H), 5.18 (d, J=13.3 Hz, 2H) , 3.46(d, J=5.9Hz, 2H), 3.04(s, 3H), 1.82-1.79(m, 3H), 1.64(s, 2H), 1.29-1.23(m, 3H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ170.7,166.8,150.9,133.0,129.3,129.2,126.4,85.5,67.1,48.7,38.1,29.3, 24.4; 13 C NMR (125 MHz, CDCl 3 ): δ 170.7, 166.8, 150.9, 133.0, 129.3, 129.2, 126.4, 85.5, 67.1, 48.7, 38.1, 29.3, 24.4;
HRMS(ESI):calcd for C17H20N2O3Se[M+H]+381.0718,found 381.0721。HRMS (ESI): calcd for C17H20N2O3Se [ M +H] + 381.0718 , found 381.0721.
实施例20Example 20
1-甲基-3-(4-哌啶甲酸甲酯基)-4-苯硒基马来酰亚胺化合物的合成Synthesis of 1-methyl-3-(4-piperidinecarboxymethyl)-4-phenylselenomaleimide
在室温下,将碘苯(0.6mmol,3equiv)、硒粉(0.6mmol,3equiv)、N-甲基马来酰亚胺(0.2mmol,1equiv)、 4-哌啶甲酸甲酯(0.3mmol,1.5equiv)、醋酸铜(0.02mmol,0.1equiv)、碳酸钠(0.8mmol,4equiv)和1mL N,-甲基吡咯烷酮加入到反应管中,然后充入氧气,并且置换三次,在120℃反应温度下搅18h。将反应混合物冷却,然后加入乙酸乙酯进行稀释,将稀释后的溶液转移至分液漏斗中,用饱和食盐水萃取,分离出水相和有机相,再用乙酸乙酯萃取水相3次,合并有机相,加入5g无水硫酸钠,静止30min,每次用5mL 乙酸乙酯洗涤滤饼共3次,然后旋掉溶剂,经柱层析分离得到产物(洗脱剂:石油醚∶乙醚=8∶1),产物为黄色液体,收率79%,产物重量为64mg。At room temperature, iodobenzene (0.6mmol, 3equiv), selenium powder (0.6mmol, 3equiv), N-methylmaleimide (0.2mmol, 1equiv), methyl 4-piperidinecarboxylate (0.3mmol, 1.5 equiv), copper acetate (0.02 mmol, 0.1 equiv), sodium carbonate (0.8 mmol, 4 equiv) and 1 mL of N,-methylpyrrolidone were added to the reaction tube, then filled with oxygen, and replaced three times, at a reaction temperature of 120 °C Stir for 18h. The reaction mixture was cooled, then diluted with ethyl acetate, the diluted solution was transferred to a separatory funnel, extracted with saturated brine, the aqueous phase and the organic phase were separated, and the aqueous phase was extracted three times with ethyl acetate, and the combined To the organic phase, add 5 g of anhydrous sodium sulfate, stand still for 30 min, wash the filter cake three times with 5 mL of ethyl acetate each time, then spin off the solvent, and separate the product by column chromatography (eluent: petroleum ether: ether=8 : 1), the product was a yellow liquid, the yield was 79%, and the weight of the product was 64 mg.
所得产物的核磁共振氢谱的数据如下:The data of the H NMR spectrum of the obtained product are as follows:
1H NMR(500MHz,CDCl3):δ7.32-7.30(m,2H),7.24-7.22(m,2H),7.19-7.17(m,1H),4.87(dt,J=13.6, 3.6Hz,2H),3.68(s,3H),3.37-3.32(m,2H),3.04(s,3H),2.62-2.56(m,1H),1.97-1.94(m,2H),1,80-1.73(m, 2H); 1 H NMR (500 MHz, CDCl 3 ): δ 7.32-7.30 (m, 2H), 7.24-7.22 (m, 2H), 7.19-7.17 (m, 1H), 4.87 (dt, J=13.6, 3.6 Hz, 2H), 3.68(s, 3H), 3.37-3.32(m, 2H), 3.04(s, 3H), 2.62-2.56(m, 1H), 1.97-1.94(m, 2H), 1,80-1.73( m, 2H);
所得产物的核磁共振碳谱的数据如下:The data of the carbon nuclear magnetic resonance spectrum of the obtained product are as follows:
13C NMR(125MHz,CDCl3):δ174.2,170.6,166.7,150.6,132.7,129.3,129.3,126.5,86.4,51.9,47.9,40.2, 28.5,24.4; 13 C NMR (125 MHz, CDCl 3 ): δ 174.2, 170.6, 166.7, 150.6, 132.7, 129.3, 129.3, 126.5, 86.4, 51.9, 47.9, 40.2, 28.5, 24.4;
HRMS(ESI):calcd for C18H20N2O4Se[M+H]+409.0667,found 409.0668。HRMS (ESI): calcd for C18H20N2O4Se [ M +H] + 409.0667 , found 409.0668.
由上述实施例1-20可看出,当采用本发明的所述方法时,能够以高产率、高纯度得到3-胺基-4-芳硒基马来酰亚胺化合物。It can be seen from the above examples 1-20 that when the method of the present invention is adopted, the 3-amino-4-arylselenylmaleimide compound can be obtained in high yield and high purity.
实施例21-23Examples 21-23
除将其中的过渡金属催化剂醋酸铜分别替换为如下的铜盐外,与实施例1相同的方式而分别实施了实施例21-23,所使用铜盐化合物和相应产物的收率如下表1所示。Except replacing the transition metal catalyst copper acetate with the following copper salts, respectively, Examples 21-23 were implemented in the same manner as in Example 1, and the yields of the copper salt compounds and corresponding products used are shown in Table 1 below. Show.
表1Table 1
由上表1可看出,当使用其它铜盐时,碘化亚铜能够顺利反应但是产物的产率下降比较大,而氯化铜和溴化铜不能够催化该反应由此证明了醋酸铜是该反应成功的关键因素,且对该反应体系最为有效。As can be seen from the above table 1, when other copper salts are used, cuprous iodide can react smoothly but the yield of the product declines relatively large, and cupric chloride and cupric bromide cannot catalyze the reaction, thus proving that cupric acetate is the key factor for the success of this reaction and is the most effective for this reaction system.
实施例24-37Examples 24-37
除将其中的有机溶剂N-甲基吡咯烷酮分别替换为如下的有机溶剂外,以与实施例1相同的方式而分别实施了实施24-37,所使用有机溶剂和相应产物的收率如下表2所示。Except that the organic solvent N-methylpyrrolidone in it was replaced with the following organic solvents, respectively, implementations 24-37 were implemented in the same manner as in Example 1, and the yields of the organic solvents used and the corresponding products were as follows in Table 2 shown.
表2Table 2
由上表2可看出,当使用其它有机溶剂时,除了在强极性溶剂二甲亚砜和N,N-二甲基乙酰胺能发生反应,但产率仍有所降低;而在非极性甚至弱配位溶剂条件下没有任何产物。这证明了有机溶剂的合适选择对反应能否进行有着显著的,甚至是决定性的影响。It can be seen from the above table 2 that when other organic solvents are used, except in the strong polar solvent dimethyl sulfoxide and N,N-dimethylacetamide can react, but the yield is still reduced; Polar or even weakly coordinating solvent conditions do not have any product. This proves that the appropriate choice of organic solvent has a significant, even decisive, effect on whether the reaction can proceed.
实施例38-39Examples 38-39
除将其中的碱碳酸钠分别替换为如下的无机碱外,以与实施例1相同的方式而分别实施了实施例 38-39,所使用碱化合物和相应产物的收率如下表3所示,证明了碳酸钠是该反应成功的关键因素。Except replacing the alkali sodium carbonate therein with the following inorganic bases, respectively, Examples 38-39 were implemented in the same manner as in Example 1, and the yields of the alkali compounds used and the corresponding products were shown in Table 3 below, It is proved that sodium carbonate is the key factor for the success of this reaction.
表3table 3
最后应说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然科研对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, but not to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: It is still scientific research to modify the technical solutions recorded in the foregoing embodiments, or to make equivalent replacements for some or all of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the technical solutions of the embodiments of the present invention. scope.
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2018114917546 | 2018-11-28 | ||
CN201811491754 | 2018-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111925310A true CN111925310A (en) | 2020-11-13 |
Family
ID=73282852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910670849.2A Pending CN111925310A (en) | 2018-11-28 | 2019-07-19 | 3-amino-4-arylseleno maleimide compound and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111925310A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115353477A (en) * | 2022-01-19 | 2022-11-18 | 温州医科大学 | A kind of preparation method of bis-selenomaleimide compound |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108558785A (en) * | 2018-02-19 | 2018-09-21 | 温州医科大学 | A kind of 5- aryl -2- arylseleno -1,3- oxazole compounds and preparation method |
CN108675961A (en) * | 2018-02-19 | 2018-10-19 | 温州医科大学 | A kind of 1- methyl -2-(2,4,6- trimethylbenzene selenos)Benzimidazole compound and preparation method |
-
2019
- 2019-07-19 CN CN201910670849.2A patent/CN111925310A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108558785A (en) * | 2018-02-19 | 2018-09-21 | 温州医科大学 | A kind of 5- aryl -2- arylseleno -1,3- oxazole compounds and preparation method |
CN108675961A (en) * | 2018-02-19 | 2018-10-19 | 温州医科大学 | A kind of 1- methyl -2-(2,4,6- trimethylbenzene selenos)Benzimidazole compound and preparation method |
Non-Patent Citations (3)
Title |
---|
DEHUA HU,等: "Copper-catalyzed diarylation of Se with aryl iodides and heterocycles", 《ORG. CHEM. FRONT.》 * |
XUE GAO,等: "Oxidative Aminoarylselenation of Maleimides via Copper-Catalyzed Four-Component Cross-Coupling", 《ORG. LETT.》 * |
ZHEN-HUA YANG等: "Three-Component Coupling Reactions of Maleimides, Thiols, and Amines: One-Step Construction of 3,4-Heteroatom-functionalized Maleimides by Copper-Catalyzed C(sp2)-H Thioamination", 《ADV. SYNTH. CATAL.》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115353477A (en) * | 2022-01-19 | 2022-11-18 | 温州医科大学 | A kind of preparation method of bis-selenomaleimide compound |
CN115353477B (en) * | 2022-01-19 | 2023-10-20 | 温州医科大学 | A kind of preparation method of diselenomaleimide compounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109651225B (en) | Preparation method of 1-methyl-3-morphinyl-4-arylmercapto maleimide compound | |
CN109705013B (en) | A kind of 1-(4-methylbenzyl)-3-amino-4-methylselenomaleimide compound and preparation method thereof | |
CN111333564B (en) | A kind of synthetic method of 3-alkylmercapto-1-methyl-4-morpholino maleimide compound | |
CN111978236A (en) | Preparation method of N-substituted-3-morpholinyl-4-phenylseleno maleimide compound | |
CN111393350A (en) | Synthesis method of N-methyl-3-substituted benzylmercapto-4-morpholinyl maleimide compound | |
CN107674044A (en) | A kind of method using carbon dioxide, amine and aryldiazonium acetic acid esters synthesis of carbamates | |
CN111440108A (en) | Synthetic method of N-substituted-3-benzylmercapto-4-morpholinyl maleimide compound | |
CN108017613A (en) | Ruthenium is catalyzed the method that heterocycle arone prepares more virtue substitution naphthalene derivativeses with tolans reaction | |
CN112028809A (en) | Preparation method of 3-amino-4-phenylseleno maleimide compound | |
CN108675948A (en) | A kind of beta-hydroxy selenide compound and preparation method | |
CN108863878A (en) | A kind of beta-hydroxy selenide compound and preparation method | |
CN108084104A (en) | 1,2,3- phentriazine -4(3H)The synthetic method of -one compound | |
CN111925310A (en) | 3-amino-4-arylseleno maleimide compound and preparation method thereof | |
CN108675961B (en) | A kind of 1-methyl-2-(2,4,6-trimethylphenylselenoyl) benzimidazole compound and preparation method | |
CN110357805B (en) | Preparation method of N-methyl-3-phenylseleno maleimide compound | |
CN106117216A (en) | A kind of method of atmospheric high efficiency synthesis 6H iso-indoles [2,1 a] indole 6 ketone compounds | |
CN111440109B (en) | Preparation method of N-methyl-3-methyl mercapto-4-amino maleimide compound | |
CN112028808B (en) | Preparation method of N-substituted-3-methyl mercapto-4-morpholinyl maleimide compound | |
CN111978237A (en) | Preparation method of 3-morpholinyl-4-arylseleno maleimide compound | |
CN102382091A (en) | Method for synthesizing multi-substituted chromone compound | |
CN102531995A (en) | 3,3'-disubstituted-3-hydroxy bis-indolinone derivative and preparation method and application thereof | |
CN107188792B (en) | Synthetic method of 2,4' -dihydroxy benzophenone compound | |
CN112661690B (en) | Preparation method of 3-chloro-4-amino maleimide compound | |
CN108558785A (en) | A kind of 5- aryl -2- arylseleno -1,3- oxazole compounds and preparation method | |
CN106008309B (en) | A kind of method that visible light catalytic prepares Isatine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201113 |